Comparative Study of Efficacy of Oral Terbinafine and Oralitraconazole in Tinea Corporis/Tinea Cruris Infection

被引:1
作者
Brigida, S. [1 ]
Elizabeth, Arul Amutha [1 ]
机构
[1] Bharath Inst Higher Educ & Res, Dept Pharmacol, Sree Balaji Med Coll & Hosp, Chennai, Tamil Nadu, India
关键词
Dermatophytoses; itraconazole; terbinafine; steroid; DOUBLE-BLIND; CHRONIC DERMATOPHYTOSIS; ITRACONAZOLE; EPIDEMIOLOGY; RESISTANCE; THERAPY;
D O I
10.9734/JPRI/2021/v33i20A31352
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dermatophytoses which are superficial fungal infections of the skin, hair, and nail are among the most common infective dermatoses seen in dermatology outpatient clinics. Today, we are facing an onslaught of chronic and recurrent dermatophytosis in volumes never encountered previously. Itraconazole was found to be the better antifungal in terms of clinical cure,mycological clearance and less need for extension of treatment than Terbinafine. Overall, oral Itraconazole 200 mg/day for 2 weeks proved to be a better agent with excellent and significantly better cure rates than oral Terbinafine 500mg/day for 2 weeks. With Itraconazole, the contra-indications, drug interactions must be kept in mind to prevent loss of efficacy/ potentially hazardous interactions. Both drugs had a good safety profile and few minor adverse events. The reasons for extension of treatment comprise chronicity, previous treatment with OTC steroid preparations, and misuse of systemic antifungal drugs, diabetes, and obesity. Poor personal practices and hygiene also havetheir contribution. Significant associations were also noted between diabetes and chronicity.
引用
收藏
页码:94 / 105
页数:12
相关论文
共 32 条
  • [1] ECOLOGY AND EPIDEMIOLOGY OF DERMATOPHYTE INFECTIONS
    ALY, R
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 31 (03) : S21 - S25
  • [2] Secreted subtilisins of Microsporum canis are involved in adherence of arthroconidia to feline corneocytes
    Baldo, Aline
    Tabart, Jeremy
    Vermout, Sandy
    Mathy, Anne
    Collard, Alfred
    Losson, Bertrand
    Mignon, Bernard
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2008, 57 (09) : 1152 - 1156
  • [3] BRAUTIGAM M, 1995, BRIT MED J, V311, P919, DOI 10.1136/bmj.311.7010.919
  • [4] Dahl M V, 1994, Adv Dermatol, V9, P97
  • [5] Decroix J, 1997, EUR J DERMATOL, V7, P353
  • [6] DelRosso JQ, 2004, PODIATRY TODAY, V116, P61
  • [7] Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis
    Evans, EGV
    Sigurgeirsson, B
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1999, 318 (7190): : 1031 - 1035
  • [8] ONE-WEEK THERAPY WITH ORAL TERBINAFINE IN CASES OF TINEA CRURIS/CORPORIS
    FARAG, A
    TAHA, M
    HALIM, S
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1994, 131 (05) : 684 - 686
  • [9] DRUG-INDUCED HEPATIC-INJURY - AN ANALYSIS OF 1100 CASES REPORTED TO THE DANISH-COMMITTEE-ON-ADVERSE-DRUG-REACTIONS BETWEEN 1978 AND 1987
    FRIIS, H
    ANDREASEN, PB
    [J]. JOURNAL OF INTERNAL MEDICINE, 1992, 232 (02) : 133 - 138
  • [10] Update in Antifungal Therapy of Dermatophytosis
    Gupta, Aditya K.
    Cooper, Elizabeth A.
    [J]. MYCOPATHOLOGIA, 2008, 166 (5-6) : 353 - 367